ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc (BTX)

9,79
0,00
( 0,00% )
Mis à jour : 01:00:00

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
9,79
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
9,79
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
5 410 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,06
Bénéfice par action (BPA)
-4,01
Chiffre d'affairess
68k
Bénéfice net
-21,68M

À propos de Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immu... Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. Show more

Secteur
Pharmaceutical Preparations
Industrie
Television Broadcast Station
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2022

BTX Dernières nouvelles

Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial Results

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing...

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Reports Inducement Grants

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts PR Newswire CAMBRIDGE, Mass., Sept. 15, 2021 CAMBRIDGE, Mass., Sept...

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET

BROOKLYN, N.Y., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine...

Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum

BROOKLYN, N.Y., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021

NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

BTX - Frequently Asked Questions (FAQ)

What is the current Brooklyn ImmunoTherapeut... share price?
The current share price of Brooklyn ImmunoTherapeut... is US$ 9,79
How many Brooklyn ImmunoTherapeut... shares are in issue?
Brooklyn ImmunoTherapeut... has 5 410 000 shares in issue
What is the market cap of Brooklyn ImmunoTherapeut...?
The market capitalisation of Brooklyn ImmunoTherapeut... is USD 52,96M
What is the 1 year trading range for Brooklyn ImmunoTherapeut... share price?
Brooklyn ImmunoTherapeut... has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Brooklyn ImmunoTherapeut...?
The price to earnings ratio of Brooklyn ImmunoTherapeut... is -0,06
What is the cash to sales ratio of Brooklyn ImmunoTherapeut...?
The cash to sales ratio of Brooklyn ImmunoTherapeut... is 19,84
What is the reporting currency for Brooklyn ImmunoTherapeut...?
Brooklyn ImmunoTherapeut... reports financial results in USD
What is the latest annual turnover for Brooklyn ImmunoTherapeut...?
The latest annual turnover of Brooklyn ImmunoTherapeut... is USD 68k
What is the latest annual profit for Brooklyn ImmunoTherapeut...?
The latest annual profit of Brooklyn ImmunoTherapeut... is USD -21,68M
What is the registered address of Brooklyn ImmunoTherapeut...?
The registered address for Brooklyn ImmunoTherapeut... is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Brooklyn ImmunoTherapeut... website address?
The website address for Brooklyn ImmunoTherapeut... is eternatx.com
Which industry sector does Brooklyn ImmunoTherapeut... operate in?
Brooklyn ImmunoTherapeut... operates in the TELEVISION BROADCAST STATION sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CTMCastellum Inc
US$ 2,25
(58,45%)
29,04M
BOILProShares Ultra Bloomberg Natural Gas New
US$ 63,1384
(23,80%)
2,44M
SATXSatixFy Communications Ltd
US$ 1,5097
(22,39%)
382,47k
UNGUnited States Natural Gas Fund LP
US$ 19,20
(21,83%)
6,97M
LODEComstock Inc
US$ 0,815
(17,74%)
16,83M
CVMCel Sci Corporation New
US$ 0,3867
(-35,56%)
3,49M
CNBSAmplify Seymour Cannabis ETF
US$ 1,86
(-33,33%)
56,68k
AMBOAmbow Education Holding Ltd
US$ 2,445
(-29,54%)
214,63k
GRFXGraphex Group Limited
US$ 0,32
(-26,44%)
1,11M
KOLDProShares UltraShort Bloomberg Natural Gas
US$ 37,69
(-23,95%)
3,72M
CTMCastellum Inc
US$ 2,25
(58,45%)
28,57M
OPTTOcean Power Technologies Inc
US$ 0,56035
(17,52%)
21,48M
UVIX2x Long VIX Futures ETF
US$ 3,738
(17,18%)
19,36M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,3326
(6,51%)
18,38M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,745
(-6,55%)
17,87M
Aucune Discussion Trouvée
Ajouter une Discussion